Sp1 is a transcription repressor to stanniocalcin-1 expression in TSA-treated human colon cancer cells, HT29

Alice Y S Law1, B H Y Yeung, L Y Ching

  • 1Department of Biology, Hong Kong Baptist University, Kowloon Tong, Hong Kong.

Insights

Specificity protein 1 (Sp1) and retinoblastoma (Rb) repress stanniocalcin-1 (STC1) gene transcription in colon cancer cells. Inhibiting Sp1 or promoting Sp1 hyperphosphorylation synergistically increases STC1 levels and apoptosis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Regulation

Background:

  • Stanniocalcin-1 (STC1) is implicated in apoptosis in HT29 colon cancer cells following histone deacetylase (HDAC) inhibitor treatment.
  • The precise mechanisms regulating STC1 expression in response to HDAC inhibitors require further elucidation.

Purpose of the Study:

  • To investigate the role of specificity protein 1 (Sp1) and retinoblastoma (Rb) in regulating STC1 gene transcription in trichostatin A (TSA)-treated HT29 cells.
  • To explore the therapeutic potential of targeting Sp1 in combination with HDAC inhibitors for colon cancer treatment.

Main Methods:

  • Cell culture of HT29 human colon cancer cells.
  • Treatment with TSA, Sp1 inhibitor mithramycin A (MTM), and protein phosphatase inhibitor okadaic acid (OKA).
  • Gene expression analysis (STC1 transcript levels, luciferase activity), apoptosis assays, Sp1 knockdown, chromatin immunoprecipitation (ChIP), and re-ChIP assays.

Main Results:

  • Sp1, in association with Rb, represses STC1 gene transcription in TSA-treated HT29 cells.
  • Co-treatment with TSA and MTM synergistically enhances STC1 expression and apoptosis.
  • Sp1 hyperphosphorylation, induced by OKA, reduces its transcriptional activity, leading to increased STC1 expression.
  • ChIP and re-ChIP assays confirm Sp1 binding to the STC1 promoter and recruitment of Rb.

Conclusions:

  • STC1 is identified as a downstream target gene regulated by Sp1.
  • Sp1 acts as a transcriptional repressor of STC1, with its activity modulated by phosphorylation and Rb association.
  • Targeting the Sp1/Rb/STC1 pathway presents a potential therapeutic strategy for colon cancer.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...